Biography

Curriculum Vitae and Bibliography    Michael M Haddadin 986840 Nebraska Medical Center Omaha, NE  68198-6840             United States of America             Office:  1-402-559-5520 Email:  [email protected]   Education:   09/2008 - 06/2014 Bachelor’s degree in medicine and surgery (MBBS), Jordan University of Science and Technology (JUST), Irbid, Jordan. 09/2024 -  Master of Science (MS), Clinical & Translational Research, University of Nebraska, Omaha, NE   Post-Degree Training:   07/2014 - 06/2015 Intern, Arab Medical Center, Amman - Jordan  06/2016 - 07/2017 Transitional Resident, Internal Medicine, King Hussein Cancer Center, Amman – Jordan  07/2017 - 06/2020 Resident, Internal Medicine, State University of New York, Downstate Health Science Center. Brooklyn, NY 07/2020 – 06/2023 Fellow, Hematology-Oncology, University of Massachusetts, Worcester, MA   Academic Appointments:  07/2016 – 06/2017 Chief Resident, Internal Medicine Residency Program, King Hussein Cancer Center, Amman – Jordan 07/2022 – 06/2023 Chief Fellow, Hematology-Oncology Department, University of Massachusetts, Worcester, MA 07/2023 - Present Assistant Professor, Hematology/Oncology Division, Department of Internal Medicine, University of Nebraska Medical Center, Fred & Pamela Buffett Cancer Center  Certifications & Licenses:  State Medical License:  07/2017 -06/2023 Limited License, Massachusetts  07/2023 – Present Michigan State Medical License 07/2023 – Present Nebraska State Medical License  Board Certification:  09/2016 ECFMG Certificate, United States Medical Licensing Examination 10/2020 American Board of Internal Medicine 02/2024 American Board of Hematology  02/2024 American Board of Clinical Oncology   Study Sections:  12/2020 – Now Temporary reviewer, Cancer Letter 04/2024 – Now Temporary reviewer, Current Problems in Cancer   Honors and Awards:  06/2008 Granted Full Scholarship through Ministry of Higher Education (Amman, Jo) funding the pursuit of Medical Degree 03/2018 Internal Medicine Research Award at the American Federation of Medical Research (AFMR), Philadelphia, PA  07/2024 Methods in Clinical Cancer Research, ASCO/AACR Workshop. La Jolla, CA. USA   Grants and Contract Support:  Industry Sponsored Clinical Trial   Title:   Funding: Role: Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia – KO-MEN-008, Multi center.  Kura Oncology, Inc.  Site Primary Investigator   Title:   Funding: Role: Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination with Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease – Multi center. Incyte, Inc Site Primary Investigator Title:   Funding: Role: A Phase II Precision Oncology Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Adults With Hematological Malignancies: the PROMISE Trial  Secondary Investigator Title:   Funding: Role:  MyeloMatch Clinical Trials. This is a cooperative group trial with different subprotocols and trials. There is a screening trial, treatment study and a measurable residual disease trial. Cooperative Group Study, NIH Site Primary Investigator   Presentations:  “Epithelial Barrier Disruption (EBD) Is The Source Of Blood Stream Infection (BSI) In Minority Inner- City Black Patients With Malignancies Or High Burden Of Comorbidities: Implication For Population Specific Studies.” American Federation of Medical Research, Eastern   Regional Meeting. Philadelphia, PA, USA. Mar/2018 “Survival from Cancer And Blood Stream Infections (BSI) Attributable To Epithelial Barrier Disruption (EBD) In Minority Black Patients With Advanced Malignancies Or Charlson Comorbidity Index >7.” American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA, USA. Mar/2018 “Two Decades of Trends In Blood Stream Infections (BSI) In Advanced Malignancy Patients With Epithelial Barrier Disruption (EBD) Building The Case Of Population Specific Studies.” American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA, USA. Mar/2018 “Doxorubicin associated takotsubo cardiomyopathy in a patient with adult T-cell leukemia/lymphoma.” American Medical Association. Resident & fellows’ section. Washington, DC, USA. Nov/2018 “Blood stream infections (BSI) survival in black patients with comorbidity index.” American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA, USA. Mar/2019 [Unable to attend] “Role Of Central Venous Catheters In Blood Stream Infections Of Patients With High Comorbidity Index.” American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA, USA. Mar/2019 [Unable to attend] “A Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMO-SD) in known Systemic Lupus Erythematosus (SLE) presenting with sudden Acute Transverse Myelitis: A Case Report and Review of Literature.” Downstate Annual Research Day. SUNY- Downstate. Brooklyn, NY, USA. Apr/2018 [Unable to attend] “Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor”. 4th International Cancer Conference Expo, Baltimore, MD, USA. Feb/2022 [Unable to attend] “Are we near a cure for Multiple Myeloma? Convert and Sustain.” Hematology Oncology Fellows Grand Round Presentation at University of Massachusetts, Worcester, MA, USA. Apr 2022 “Precision Therapy For AML; Past, Present, & Future?” Grand Round presentation at Roswell Park Cancer Institute, Buffalo, NY. Aug 2022 “Precision Therapy for AML; With a Focus on TP53”. Grand Round Presentation at University of Massachusetts, Worcester, MA, USA. May 2023 “Donor Selection in Allogenic Stem Cell Transplant”. Grand Round Presentation at University of Nebraska, Fred & Pamela Buffet Cancer Center, Omaha, NE. Apr 2024 “Beyond The Marrow: The Detrimental Effects of Clonal Hematopoiesis”. Internal Medicine, Departmental Grand Round Presentation at University of Nebraska, Internal Medicine Department, Omaha, NE. Nov 2024   Publications: Articles published in Scholarly Journals: Al-Sadawi M, Haddadin M, Capric V, McFarlane SI. Argatroban-refractory, Heparin-induced Thrombocytopenia after Coronary Intervention with Radial Artery Occlusion. Am J Med Case Rep. 2019;7(9):184-190. doi: 10.12691/ajmcr-7-9-1. Epub 2019 Jul 14. PMID: 31396555; PMCID: PMC6687314. Haddadin M, Al-Sadawi M, Madanat S, Tam E, Taiwo E, Luhrs C, Mcfarlane SI. Late Presentation of Carfilzomib Associated Thrombotic Microangiopathy. Am J Med Case Rep. 2019;7(10):240-243. doi: 10.12691/ajmcr-7-10-5. Epub 2019 Jul 31. PMID: 31457071; PMCID: PMC6711615. Mubarak G, Haddadin M, Samra B, Luhrs C, Taiwo E. Doxorubicin-associated takotsubo cardiomyopathy in a patient with adult T-cell leukemia/lymphoma. Clin Case Rep. 2019 Nov 8;7(12):2466-2471. doi: 10.1002/ccr3.2504. PMID: 31893081; PMCID: PMC6935604. Haddadin M, Al-Sadawi M, Madanat S, McKenzie DS, Lewis R, McFarlane SI. A Case Report of Intraoperative Coagulopathy Secondary to Chronic Vitamin K Deficiency. Am J Med Case Rep. 2019;7(8):167-169. doi: 10.12691/ajmcr-7-8-4. Epub 2019 Jul 11. PMID: 31457073; PMCID: PMC6711617. Khudiakov A, Al-Sadawi M, Qin J, Haddadin M, Soroka S, Hartt A, Soni L, Arora S, McFarlane SI. Rare Case of Rectal Mixed Adeno-Neuroendocrine Carcinoma. Am J Med Case Rep. 2019;7(6):117-120. doi: 10.12691/ajmcr-7-6-5. PMID: 31321296; PMCID: PMC6639042. Al-Sadawi M, Taitt HA, Haddadin M, Shaikh S, Almasri M, Hartt A, McFarlane SI. "Coronary Confusion" Congenital Anomaly of the Left Main Coronary Artery Presenting as a Myocardial Infarction in a Young Female. Am J Med Case Rep. 2019;7(3):41-45. doi: 10.12691/ajmcr-7-3-3. Epub 2019 Mar 20. PMID: 31396549; PMCID: PMC6687077. Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A Jr, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Blood. 2019 Aug 22;134(8):678-687. doi: 10.1182/blood.2019001144. Epub 2019 Jun 26. PMID: 31243042; PMCID: PMC6706810. Aypar U, Taylor J, Garcia JS, Momeni-Boroujeni A, Gao Q, Baik J, Londono D, Benayed R, Sigler A, Haddadin M, Penson AV, Arcila ME, Mullaney K, Sukhadia P, Quesada AE, Roshal M, Cullen N, Lako A, Rodig SJ, Goldberg AD, Zhang Y, Xiao W, Ho C. P2RY8-CRLF2Fusion-Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel Therapy. JCO Precis Oncol. 2020; 4:152-160. doi: 10.1200/PO.19.00294. Epub 2020 Mar 5. PMID: 32395681; PMCID: PMC7213523. Haddadin M, Taylor J. Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm. Hematol Oncol Clin North Am. 2020 Jun;34(3):539-552. doi: 10.1016/j.hoc.2020.01.011. Epub 2020 Mar 18. PMID: 32336418. Dey P, Green AK, Haddadin M, Bach PB, Mitchell AP. Trends in Female Representation on NCCN Guideline Panels. J Natl Compr Canc Netw. 2020 Aug;18(8):1084-1086. doi: 10.6004/jnccn.2020.7571. PMID: 32755977; PMCID: PMC8354245. Al-Sadawi M, Singh K, Capric V, Mohiuddin A, Haddadin M, Nunez A, Shaikh S, Bukharovich I, McFarlane SI. Incidence and Associated Risk Factors of Chemotherapy-Induced Cardiomyopathy in the African American and Afro-Caribbean Populations. Int J Clin Res Trials. 2020;5:154. doi: 10.15344/2456-8007/2020/154. Epub 2020 Dec 9. PMID: 33511317; PMCID: PMC7839991. Taylor J, Mi X, North K, Binder M, Penson A, Lasho T, Knorr K, Haddadin M, Liu B, Pangallo J, Benbarche S, Wiseman D, Tefferi A, Halene S, Liang Y, Patnaik MM, Bradley RK, Abdel-Wahab O. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 2020 Sep 24;136(13):1477-1486. doi: 10.1182/blood.2020006868. PMID: 32640014; PMCID: PMC7515689. Taylor J, Donoghue MT, Ho C, Petrova-Drus K, Al-Ahmadie HA, Funt SA, Zhang Y, Aypar U, Rao P, Chavan SS, Haddadin M, Tamari R, Giralt S, Tallman MS, Rampal RK, Baez P, Kappagantula R, Kosuri S, Dogan A, Tickoo SK, Reuter VE, Bosl GJ, Iacobuzio-Donahue CA, Solit DB, Taylor BS, Feldman DR, Abdel-Wahab O. Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor. J Clin Invest. 2020 Dec 1;130(12):6668-6676. doi: 10.1172/JCI139682. PMID: 32897884; PMCID: PMC7685753. Lanjewar S, McFarlane IM, Parker KN, Saad H, Haddadin M, Hirsch E, Benyaminov F, Kecelli M, Lazaro D, Bukhari Z, Gupta R, Haseeb MA. Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies. Medicine (Baltimore). 2021 May 28;100(21):e25985. doi: 10.1097/MD.0000000000025985. PMID: 34032713; PMCID: PMC8154385. Wang X, Patel SA, Haddadin M, Cerny J. Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus. Ther Adv Infect Dis. 2021 May 24; 8:20499361211018027. doi: 10.1177/20499361211018027. PMID: 34104434; PMCID: PMC8155777. Mitchell AP, Mishra A, Dey P, Curry MA, Trivedi NU, Haddadin M, Rahman MW, Winn AN, Dusetzina SB, Bach PB. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines. Oncologist. 2021 Sep;26(9):771-778. doi: 10.1002/onco.13823. Epub 2021 May 26. Erratum in: Oncologist. 2021 Sep 21;: PMID: 33982829; PMCID: PMC8417859. Shah, B., Mattison, R. J., Abboud, R., Abdelmessieh, P., Aldoss, I., Burke, P. W., DeAngelo, D. J., Dinner, S., Fathi, A. T., Gauthier, J., Haddadin, M., Jain, N., Jonas, B., Kirby, S., Liedtke, M., Litzow, M., Logan, A., Long, M., Luger, S., Mangan, J. K., Massaro, S., May, W., Oluwole, O., Park, J., Przespolewski, A., Rangaraju, S., Saygin, C., Schwartz, M., Shami, P., & Tomlinson, B. (2024). Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(8), 563–576. https://doi.org/10.6004/jnccn.2024.0051 Trinh, J. Q., Nilles, J. D., Ellithi, M., Haddadin, M. M., Maness-Harris, L., Gundabolu, K., Wichman, C. S., & Bhatt, V. R. Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors. Future Oncology. 2024 Nov 24. doi: 10.1080/14796694.2024.2431476. Shah B, Mattison RJ, Abboud R, Abdelmessieh P, Aldoss I, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J, Haddadin M, Jain N, Jonas B, Kirby S, Liedtke M, Litzow M, Logan A, Long M, Luger S, Mangan JK, Massaro S, May W, Oluwole O, Park J, Przespolewski A, Rangaraju S, Saygin C, Schwartz M, Shami P, Tomlinson B, Webster J, Awotiwon A, Stehman K. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Lymphoblastic Leukemia V.3.2024  Abstracts Presented in National Conferences: Haddadin M, Anuforo J, Tam E, Shapira I.  Epithelial Barrier Disruption (EBD) Is The Source Of Blood Stream Infection (BSI) In Minority Inner- City Black Patients With Malignancies Or High Burden Of Comorbidities: Implication For Population Specific Studies.  American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA. Mar 2018 Haddadin M, Anuforo J, Maithel N, Shapira I.  Survival from Cancer And Blood Stream Infections (BSI) Attributable To Epithelial Barrier Disruption (EBD) In Minority Black Patients With Advanced Malignancies Or Charlson Comorbidity Index >7.  American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA. Mar 2018 Ramsaroop V, Haddadin M, Poroscnicu E. A Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMO-SD) in known Systemic Lupus Erythematosus (SLE) presenting with sudden Acute Transverse Myelitis: A Case Report and Review of Literature. Downstate Annual Research Day. SUNY- Downstate. Brooklyn, NY. Apr 2018 Haddadin M, Anuforo J, Shapira I.  Two Decades of Trends In Blood Stream Infections (BSI) In Advanced Malignancy Patients With Epithelial Barrier Disruption (EBD) Building The Case Of Population Specific Studies. American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA. Mar 2018 Haddadin M, Mubarak G, Samra B, Levitt C, Taiwo E. Doxorubicin associated takotsubo cardiomyopathy in a patient with adult T-cell leukemia/lymphoma. American Medical Association. Resident & fellows’ section. Washington, DC. Nov 2018 Haddadin M, Anuforo J, Sultan G, Oseni E, Xia J, Lewis A, Shapira I. Blood stream infections (BSI) survival in black patients with comorbidity index. American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA. Mar 2019 Haddadin M, Anuforo J, Sultan G, Oseni E, Xia J, Lewis A, Shapira I.  Role Of Central Venous Catheters In Blood Stream Infections Of Patients With High Comorbidity Index. American Federation of Medical Research, Eastern Regional Meeting. Philadelphia, PA. Mar 2019 Al-Sadawi M, Taitt H, Haddadin M, Shaikh S, Almasri M, Hartt A, McFarlane SI.  Coronary Confusion: Congenital Anomaly of the Left Main Coronary Artery Presenting as a Myocardial Infarction in a Young Female. American College of Cardiology (ACC) Vol 73. Mar 2019 Al-Sadawi M, Taitt H, Haddadin M, Shaikh S, Almasri M, Hartt A, McFarlane SI.  Coronary Confusion: Congenital Anomaly of the Left Main Coronary Artery Presenting as a Myocardial Infarction in a Young Female. American College of Cardiology (ACC), New Orleans, LA. Mar 2019 Joseph J, Kim C, Dronamraju V, Haddadin M, Neurgaonkar S.  Increasing Advance Care Planning in Elderly Patients Through Clinic Handouts. Downstate Annual Research Day. SUNY- Downstate. Brooklyn, NY. Apr 2019 Al-Sadawi M, Haddadin M, Capric V, McFarlane SI. Argatroban-refractory, Heparin-induced Thrombocytopenia after Coronary Intervention with Radial Artery Occlusion. Downstate Annual Research Day. SUNY- Downstate. Brooklyn, NY. Apr 2019 Al-Sadawi M, Singh K, Mohiuddin A, Capric V, Haddadin M, Shaikh S, Bukharovich I. Improving Compliance and Follow-Up for Chemotherapy-Induced Heart Failure in an Urban Underserved Tertiary Hospital.  Circulation. Vol 12. Apr 2019 Al-Sadawi M, Singh K, Mohiuddin A, Capric V, Haddadin M, Shaikh S, Bukharovich I.  Improving Compliance and Follow-Up for Chemotherapy-Induced Heart Failure in an Urban Underserved Tertiary Hospital. American Heart Association Quality of Care and Outcomes Research (AHA QCOR). Arlington, VA. Apr 2019 Bhatt VR, Wichman C, Koll T, Fisher A, Wildes TM, Haddadin M, Berger A, Armitage JA, Holstein SA, Maness L, Gundabolu K. Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial. 65th American Society of Hematology Annual Meeting and Exposition, San Diego, CA, United States. Dec 2023 Trinh J Q, Ellithi M, Nilles J D, Gundabolu Krishna, Haddadin M, Maness-Harris L, Wichman C S, Bhatt V R. Symptom Burden in Allogeneic Hematopoietic Stem Cell Transplantation (HCT). American Society of Clinical Oncology (ASCO) Conference. Chicago, IL. June 2024 Saadeh, A., Al-Bitar, F., Al Ta’ani, O., Abdulelah, A. A., Usmani, A. A., Jibrin, D., Haddadin, M., & Scott, K. The burden of leukemia in the United States from 1990 to 2021. 66th ASH Annual Meeting and Exposition, San Diego, CA, United States. Dec 2024 Guru Murthy, G. S., Ball, S., Feld, J., Abboud, R., Haddadin, M., Patel, S. A., Kishtagari, A., Hawkins, H., Guerra, V., Dworkin, E., Tawfiq, R. K., Dulak, D., Feng, A., Cotte, C., Cohen-Nowak, A., Shukla, A., Balasubramanian, S. K., Winer, E. S., Foucar, C., Abaza, Y., Shallis, R. M., Lin, C., Badar, T., Patel, A. A., Im, A., Szabo, A., & Atallah, E. L. Clinical utilization and outcomes of hypomethylating agents and venetoclax in patients with myelodysplastic syndrome – a multicenter retrospective analysis. 66th ASH Annual Meeting and Exposition, San Diego, CA, United States. Dec 2024. Haddadin, M., Obedat, A., Al-Bitar, F., Maness, L., Gundabolu, K., Patel, S. A., & Bhatt, V. R. Association between malnutrition and inpatient mortality in hematopoietic stem cell transplant (HSCT) population: A nationwide inpatient sample (NIS) database analysis. 66th ASH Annual Meeting and Exposition, San Diego, CA, United States. Dec 2024. Koll, T. T., Kerns, M., Wildes, T. M., Bhatt, V. R., Gundabolu, K., Maness, L., Haddadin, M., Free, M., Lyden, E. R., Murman, D. L., & Fisher, A. L. Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT. 66th ASH Annual Meeting and Exposition, San Diego, CA, United States. Dec 2024.   Books published or in preparation for publication: Haddadin M, Patel SA. Isolating leukemia cancer stem cell.  In “Stepwise Laboratory Procedure to isolate adult Stem Cells”. Draft.  Chapters in books Haddadin M,   Anwar A, Hurez S, Luhrs C. Plasma Cell Dyscrasias. In McFarlane S, Salifu M, Geraghty, Douglas T, Yusupov D, Zhyvotovska A (Ed.). Resident Inpatient Selective E-manual (RISE) Handbook (First Edition). New York, USA. Suny Downstate Medical Center, Aug 2020. Haddadin M, Noel J, Chen R, Luhrs C. Tumor Lysis Syndrome. In McFarlane S, Salifu M, Geraghty, Douglas T, Yusupov D, Zhyvotovska A (Ed.). Resident Inpatient Selective E-manual (RISE) Handbook (First Edition). New York, USA. Suny Downstate Medical Center, Aug 2020. Haddadin M, Cerny J. Multiple Myeloma. In Domino FJ , Baldor RA, Barry KA, Golding J, Stephens MB (Ed.). The 5-Minute Clinical Consult 2022 (30th Edition). Philadelphia, USA. Wolters Kluwer Health Inc. June 2021. Haddadin M, Cerny J. Multiple Myeloma, In Domino FJ , Baldor RA, Barry KA, Golding J, Stephens MB (Ed.). The 5-Minute Clinical Consult 2023 (31st Edition). Philadelphia, USA. Wolters Kluwer Health Inc. Mar 2022. Haddadin M, Gultawatvichai G. Disseminated Intravascular Coagulation. In Ferri F (Ed.). Ferri’s Clinical Advisor (First Edition). Philadelphia, USA. Elsevier Inc. Aug 2023.  Educational / Teaching Activities:  Recurrent Residents Lectures  07/2021 – 06/2023 Approach To plasma Cell neoplasm UMass Internal Medicine Residents Quarterly  09/2021 – 06/2023 Chronic Myeloid Leukemia UMass Internal Medicine Residents Quarterly  02/2024 – Ongoing Approach To Acute Leukemia UNMC Internal Medicine Residents Monthly  Recurrent Fellowship Lectures  07/2024 –  Red Blood Cell Disorder UNMC Hematology Oncology Fellowship Program  Annually 12/2024 -  Approach To Aplastic Anemia UNMC Hematology Oncology Fellowship Program  Annually   Mentoring Activities  07/2017 – 06/2022 Dawod Al Dawod Internal Medicine Resident SUNY Downstate. Brooklyn, NY 07/2022 – Ongoing Samer Jumean Internal Medicine Resident Saint Michael’s Center. Newark, NJ 10/2023 – Ongoing  Logan Baumberger Medical Student – M3 UNMC – College of Medicine.Omaha,NE 09/2024 – Ongoing Muhammad Ali Hematology Oncology Fellow UNMC. Omaha, NE   Committees Assignments:  National & International Committees:  10/2023 – Now Member, Myeloid Malignancies Working Group, Big Ten Cancer Research Consortium 10/2023 – Now Member, Bone Marrow/Stem Cell Transplant Working Group, Big Ten Cancer Research Consortium 11/2023 – Now Member, representative of the Fred & Pamela Buffet Cancer Center on the National Comprehensive Cancer Center (NCCN) Acute Lymphoblastic Leukemia (ALL) Guidelines Panel.  12/2023 – Now Member, Working Committee, Center for International Blood & Marrow Transplant Research (CIBMTR) Acute & Chronic Leukemia Committee 12/2023 – Now Member, Working Committee, Center for International Blood & Marrow Transplant Research (CIBMTR) Acute Graft Versus Host Disease (GVHD) Committee  Institutional Committees: 07/2019 – 06/2020 Member, SUNY Downstate Residency Educational Committee  07/2021 – 06/2023 Member, Hematology Oncology Research Interest Group, University of Massachusetts 07/2022 – 06/2023 Member, Hematology Oncology Wellness Fellowship Committee, University of Massachusetts 07/2023 – Ongoing  Member, Leukemia & Allo Transplant, Disease Focus Team. University of Nebraska Medical Center  03/2024 – Ongoing Member, Scientific Review Committee, University of Nebraska Medical Center.  07/2024 – Ongoing Member, Fellowship Selection Committee, University of Nebraska Hematology Oncology Program. Omaha, NE.    Memberships:  09/2011 - 04/2014 International Foundation of Medical Students Association (IFMSA). 07/2017 - Present American Medical Association (AMA) 03/2018 - Present American Federation of Medical Research (AFMR) 07/2018 - Present American College of Physicians (ACP) 10/2018 - Present American Society of Hematology (ASH) 07/2020 - Present American Society of Clinical Oncology (ASCO) 04/2021 - Present American Society of Transplantation & Cellular Therapy (ASTCT) 10/2023 - Present Big Ten Cancer Research Consortium 12/2023 - Present  Center for International Blood & Marrow Transplant Research (CIBMTR)    Community Service / Outreach:  07/2011 – 04/2014 Multiple campaigns during medical school illustrating the importance of compliance to primary care visits and age-appropriate cancer screening. Irbid, Jordan.  03/2010 – 06/2012 West Amman Community. Medical Volunteer. Amman, Jordan. 06/2004 – 09/2010 Local Scouts and Guides. Amman, Jordan.           Teaching and invited presentations:    Journal clubs Mortality and morbidity conferences (quaterly) Tumour board presentations (weekly) Hematology lectures to Internal Medicine house-staff, residents, fellows, medical students (2-4 per month)